Cooperative Group Chairmen Told They Must Do Their Own Planning, Will Get Funds Increase
In Brief: French 10 Years Behind In Treatment Techniques, Rauscher Tells Premier; European Interest Grows
CCIRC Loses Policy Making, Protocol Review
Anti-NCI Forces Fail to Raid $70 Million from Cancer Program
No Interest Seen Yet In Specialized Centers For Environmental Carcinogenesis
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”









